Re:In its fight to keep drug prices high, big pharma leans o...
by refurb on Monday April 29, 2019 @05:07PM
(#19782630)
New discoveries coming out of academia are lucky if they are a decade and hundreds of millions of dollars away from being an actual drug. Usually what comes out of academia is an idea or starting point, not a drug.
And no, drug innovation is not highly subsidized by the gov't. Just look at budgets. NIH budget is $38B, of which a fraction is actually spent on research leading to new drugs. PhRMA (just the largest drug companies) spent $71B in 2017.[1] And that ignores the billions spent by VCs to fund start-ups, another $13B in the first 10 months of 2017.[2]
Adding it up, private spending on drug R&D is probably 5-10x that of what the gov't spends.
And no, drug innovation is not highly subsidized by the gov't. Just look at budgets. NIH budget is $38B, of which a fraction is actually spent on research leading to new drugs. PhRMA (just the largest drug companies) spent $71B in 2017.[1] And that ignores the billions spent by VCs to fund start-ups, another $13B in the first 10 months of 2017.[2]
Adding it up, private spending on drug R&D is probably 5-10x that of what the gov't spends.
[1]https://www.biopharmadive.com/news/phrma-research-developmen... [2]http://www.pharmatimes.com/magazine/2018/december_2018/a_rec...